Scientists at Bonn University in Germany uncovered the chemical can help the mind during lab tests on mice.
It’s not the first time the drug has been linked to health benefits. Last week mum Marianne Dickson, from Edinburgh told how she uses cannabidiol (CBD) to treat her chronic spinal condition as well as her dog Honey’s anxiety.
She said: “People need to understand there are different components in cannabis and each on their own can have different effects. “This study is showing THC can help improve brain function while cannabidiol, which I use, helps with pain.”
While cannabis itself is still illegal, products containing CBD — which has no psychoactive components — can be classified as medicines by the British Government.
Whilst in ISRAEL, Therapix who recently uplisted to NASDAQ have been working with ultra low dose THC as part of its BrainBright Pharma program of Therapix is targeted to the high value and underserved CNS market of mild cognitive impairment (MCI) using ultra low-dose THC.
This program is scheduled to begin a Phase I study in Q1 2017. Recent studies have found that an ultra-low dose of THC protects the brain from long-term cognitive impairment which may be caused by lack of oxygen supply, seizures or use of drugs.